Clinical Trial Update: Targeted Naltrexone for Problem Drinkers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for targeted naltrexone in problem drinkers indicates the study has completed. The sponsor is UConn Health and the conditions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Alcohol Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: UConn Health | Conditions: Alcoholism, Alcohol Drinking | Phase 4 | Status: COMPLETED